Home
Welcome
Image Gallery
Video Atlas
Overview of Colorectal Papers
Colorectal Library

 

- Click on the title of each paper to access MedLine abstract at NLM site
Treatment of hepatic and pulmonary metastases

                                                          <return>


 
 
 

Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Gao J, Knutsen A, Arbman G, Carstensen J, Frĺnlund B, Sun XF. Dig Liver Dis. 2008 Nov 25.

Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Steele RJ, McClements P, Libby G, Black R, Morton C, Birrell J, Mowat AN, Wilson J, Kenicer M, Carey FA, Fraser CG. Gut. 2008 Nov 26

Population screening for colorectal cancer: the implications of an ageing population. Macafee DA, Waller M, Whynes DK, Moss S, Scholefield JH. Br J Cancer. 2008 Nov 25.

Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification? Byfield SA, Syngal S. Am J Gastroenterol. 2008 Nov;103(11):2837-40.

Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Koyanagi K, Bilchik AJ, Saha S, Turner RR, Wiese D, McCarter M, Shen P, Deacon L, Elashoff D, Hoon DS. Clin Cancer Res. 2008 Nov 15;14(22):7391-6.

Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: A risk factor for colon cancer. Patel BB, Yu Y, Du J, Levi E, Phillip PA, Majumdar AP. Biochem Biophys Res Commun. 2008 Nov 14

Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Burnett-Hartman AN, Newcomb PA, Potter JD. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):2970-9.

Association between fecal bile acids and colorectal cancer: a meta-analysis of observational studies. Tong JL, Ran ZH, Shen J, Fan GQ, Xiao SD. Yonsei Med J. 2008 Oct 31;49(5):792-803.

Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men. Chiu HM, Lin JT, Chen TH, Lee YC, Chiu YH, Liang JT, Shun CT, Wu MS. Am J Gastroenterol. 2008 Sep;103(9):2317-25.

Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL. Ann Intern Med. 2008 Oct 7;149(7):441-50, W81.

Pathological predictors for lymph node metastasis in T1 colorectal cancer. Yamauchi H, Togashi K, Kawamura YJ, Horie H, Sasaki J, Tsujinaka S, Yasuda Y, Konishi F. Surg Today. 2008;38(10):905-10.

Five-year risk of colorectal neoplasia after negative screening colonoscopy. Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. N Engl J Med. 2008 Sep 18;359(12):1218-24.

Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M, Richel DJ, Stassi G, Medema JP. Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13427-32.

Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Julié C, Trésallet C, Brouquet A, Vallot C, Zimmermann U, Mitry E, Radvanyi F, Rouleau E, Lidereau R, Coulet F, Olschwang S, Frébourg T, Rougier P, Nordlinger B, Laurent-Puig P, Penna C, Boileau C, Franc B, Muti C, Hofmann-Radvanyi H. Am J Gastroenterol. 2008 Nov;103(11):2825-35; quiz 2836.

A simplified, noninvasive stool DNA test for colorectal cancer detection. Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Markowitz S, Paszat L, Berger BM. Am J Gastroenterol. 2008 Nov;103(11):2862-70.

A stochastic model for cancer stem cell origin in metastatic colon cancer. Odoux C, Fohrer H, Hoppo T, Guzik L, Stolz DB, Lewis DW, Gollin SM, Gamblin TC, Geller DA, Lagasse E. Cancer Res. 2008 Sep 1;68(17):6932-41.

Cancer health disparities among Indian and Pakistani immigrants in the United States: a Surveillance, Epidemiology, and End Results-based study from 1988 to 2003. Hossain A, Sehbai A, Abraham R, Abraham J. Cancer. 2008 Sep 15;113(6):1423-30.

Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Gut. 2008 Nov;57(11):1545-53.

Demographic differences between cancer survivors and those who die quickly of their disease. Groome PA, Schulze KM, Keller S, Mackillop WJ. Clin Oncol (R Coll Radiol). 2008 Oct;20(8):647-56.

Risk factors for development of desmoid tumours in familial adenomatous polyposis. Lefevre JH, Parc Y, Kernéis S, Goasguen N, Benis M, Parc R, Tiret E. Br J Surg. 2008 Sep;95(9):1136-9.

C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA. Int J Cancer. 2008 Sep 1;123(5):1133-40. Review.

Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. Zhao YS, Wang F, Chang D, Han B, You DY. Int J Colorectal Dis. 2008 Sep;23(9):875-82.

Modification of the associations between lifestyle, dietary factors and colorectal cancer risk by APC variants. Theodoratou E, Campbell H, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, Porteous ME, Dunlop MG, Farrington SM. Carcinogenesis. 2008 Sep;29(9):1774-80.

A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence. Wang Y, Jacobs EJ, Patel AV, Rodríguez C, McCullough ML, Thun MJ, Calle EE. Cancer Causes Control. 2008 Sep;19(7):783-92.

The diagnostic value of digital rectal examination in primary care for palpable rectal tumour. Ang CW, Dawson R, Hall C, Farmer M. Colorectal Dis. 2008 Oct;10(8):789-92.

Adam R, de Haas RJ, Wicherts DA, Aloia TA, Delvart V, Azoulay D, Bismuth H, Castaing D. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol. 2008 Aug 1;26(22):3672-80.

Bajwa A, Blunt N, Vyas S, Suliman I, Bridgewater J, Hochhauser D, Ledermann JA, O'Bichere A. Primary tumour resection and survival in the palliative management of metastatic colorectal cancer. Eur J Surg Oncol. 2008 Jul 20.

Hillingsř JG, Wille-Jřrgensen P. Staged or simultaneous resection of synchronous liver metastases from colorectal cancer - A systematic review. Colorectal Dis. 2008 Jul 11.

Aoki T, Umekita N, Tanaka S, Noda K, Warabi M, Kitamura M. Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin. Surgery. 2008 Jun;143(6):706-14.

Mueller L, Hillert C, Möller L, Krupski-Berdien G, Rogiers X, Broering DC.  Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol. 2008 Jul;15(7):1908-17.

Tanaka K, Shimada H, Matsumoto C, Matsuo K, Takeda K, Nagano Y, Togo S. Impact of the Degree of Liver Resection on Survival for Patients with Multiple Liver Metastases from Colorectal Cancer. World J Surg. 2008 May 3.

Fidarova EF, El-Emir E, Boxer GM, Qureshi U, Dearling JL, Robson MP, Begent RH, Trott KR, Pedley RB. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy. Clin Cancer Res. 2008 May 1;14(9):2639-46.

Al-Asfoor A, Fedorowicz Z, Lodge M. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006039. Review. 

Guzzetti E, Pulitanň C, Catena M, Arru M, Ratti F, Finazzi R, Aldrighetti L, Ferla G. Impact of type of liver resection on the outcome of colorectal liver metastases: a case-matched analysis. J Surg Oncol. 2008 May 1;97(6):503-7.

Fuks D, Cook MC, Bréhant O, Henegar A, Dumont F, Chatelain D, Yzet T, Mulieri G, Joly JP, Nguyen-Khac E, Dupas JL, Mauvais F, Verhaeghe P, Regimbeau JM.  Colorectal carcinoma with potentially resectable metastases: Factors associated with the failure of curative schedule. Gastroenterol Clin Biol. 2008 Apr;32(4):390-400.

Eisenberger A, Whelan RL, Neugut AI. Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review. Int J Colorectal Dis. 2008 Jun;23(6):559-68.

Funaioli C, Longobardi C, Martoni AA.  The impact of chemotherapy on overall survival and quality of life of patients with metastatic colorectal cancer: a review of phase III trials. J Chemother. 2008 Feb;20(1):14-27.

Lordan JT, Karanjia ND, Quiney N, Fawcett WJ, Worthington TR. A 10-year study of outcome following hepatic resection for colorectal liver metastases - the effect of evaluation in a multidisciplinary team setting. Eur J Surg Oncol. 2008 Mar 5

Tabernero J, Pfeiffer P, Cervantes A. Administration of cetuximab every 2 weeks in the treatment of metastatic colorectal cancer: an effective, more convenient alternative to weekly administration? Oncologist. 2008 Feb;13(2):113-9.

Nuzzo G, Giuliante F, Ardito F, Vellone M, Giovannini I, Federico B, Vecchio FM. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery. 2008 Mar;143(3):384-93.

Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S. Role of hepatectomy in treating multiple bilobar colorectal cancer metastases. Surgery. 2008 Feb;143(2):259-70.

Robertson JH, Iga AM, Sales KM, Winslet MC, Seifalian AM. Integrins: a method of early intervention in the treatment of colorectal liver metastases. Curr Pharm Des. 2008;14(3):296-305. Review.

Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, DeMatteo RP, Blumgart LH, D'Angelica M. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg. 2008 Jan;247(1):109-17.

Arru M, Aldrighetti L, Castoldi R, Di Palo S, Orsenigo E, Stella M, Pulitanň C, Gavazzi F, Ferla G, Di Carlo V, Staudacher C. Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg. 2008 Jan;32(1):93-103.

Hamady ZZ, Malik HZ, Alwan N, Wyatt JI, Prasad KR, Toogood GJ, Lodge JP. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome. Eur J Surg Oncol. 2008 Feb;34(2):180-4.

Rotolo N, De Monte L, Imperatori A, Dominioni L. Pulmonary resections of single metastases from colorectal cancer. Surg Oncol. 2007 Dec;16 Suppl 1:S141-4. Epub 2007 Nov 26.

Arru M, Aldrighetti L, Castoldi R, Di Palo S, Orsenigo E, Stella M, Pulitanň C, Gavazzi F, Ferla G, Di Carlo V, Staudacher C. Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg. 2008 Jan;32(1):93-103.

Kornprat P, Jarnagin WR, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M. Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. Arch Surg. 2007 Nov;142(11):1087-92.

Treska V, Skalicky T, Liska V, Ferda J. Repeated procedures for colorectal liver metastases. Hepatogastroenterology. 2007 Sep;54(78):1775-8.

Brent A, Talbot R, Coyne J, Nash G. Should indeterminate lung lesions reported on staging CT scans influence the management of patients with colorectal cancer?Colorectal Dis. 2007 Nov;9(9):816-8.

Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D'Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007 Oct 10;25(29):4575-80.

Furák J, Troján I, Szöke T, Wolfárd A, Nagy E, Németh I, Tiszlavicz L, Lázár G. Lung cancer as a second primary malignant tumor: prognostic values after surgical resection. Interact Cardiovasc Thorac Surg. 2008 Feb;7(1):50-3. Epub 2007 Oct 9.

Malik HZ, Farid S, Al-Mukthar A, Anthoney A, Toogood GJ, Lodge JP, Prasad KR. A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. Ann Surg Oncol. 2007 Dec;14(12):3519-26. Epub 2007 Oct 3.

Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?Ann Surg Oncol. 2008 Jan;15(1):144-57. Epub 2007 Sep 29.

Siperstein AE, Berber E, Ballem N, Parikh RT. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg. 2007 Oct;246(4):559-65; discussion 565-7.

Tang PA, Bentzen SM, Chen EX, Siu LL. Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy. J Clin Oncol. 2007 Oct 10;25(29):4562-8. Epub 2007 Sep 17. Review.

Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg. 2007 Nov;11(11):1498-504; discussion 1504-5. Epub 2007 Sep 11.

Suppiah A, White TJ, Roy-Choudhury SH, Breen DJ, Cast J, Maraveyas A, Hartley JE, Monson JR. Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomes. Dig Surg. 2007;24(5):358-60. Epub 2007 Sep 4.

Nordlinger B, Van Cutsem E, Rougier P, Köhne CH, Ychou M, Sobrero A, Adam R, Arvidsson D, Carrato A, Georgoulias V, Giuliante F, Glimelius B, Golling M, Gruenberger T, Tabernero J, Wasan H, Poston G; European Colorectal Metastases Treatment Group. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer. 2007 Sep;43(14):2037-45. Epub 2007 Sep 4. Review.

Zhang HZ, Dong SX, Zhou ZX, Shao YF. [Outcome of surgical therapy for liver metastasis of colorectal cancer: analysis of 75 cases] Zhonghua Yi Xue Za Zhi. 2007 Jun 5;87(21):1457-61. Chinese.  

Vibert E, Bretagnol F, Alves A, Pocard M, Valleur P, Panis Y. Multivariate Analysis of Predictive Factors for Early Postoperative Death After Colorectal Surgery in Patients with Colorectal Cancer and Synchronous Unresectable Liver Metastases. Dis Colon Rectum. 2007 Aug 21 

Liska V, Holubec L Jr, Treska V, Skalicky T, Sutnar A, Kormunda S, Pesta M, Finek J, Rousarova M, Topolcan O. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases. Anticancer Res. 2007 Jul-Aug;27(4C):2861-4.  

Kemeny N. Presurgical chemotherapy in patients being considered for liver resection. Oncologist. 2007 Jul;12(7):825-39.

Are C, Gonen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, Blumgart LH, D'Angelica M. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg. 2007 Aug;246(2):295-300.

Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR, D'Angelica M, Fong Y, Blumgart LH, DeMatteo RP. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg. 2007 Aug;205(2):231-8

Al-Asfoor A, Fedorowicz Z. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006039.

Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series.
Ann Thorac Surg. 2007 Jul;84(1):324-38. Review.

Welter S, Jacobs J, Krbek T, Krebs B, Stamatis G. Long-term survival after repeated resection of pulmonary metastases from colorectal cancer.
Ann Thorac Surg. 2007 Jul;84(1):203-10.

Ahmad A, Chen SL, Bilchik AJ. Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases. Arch Surg. 2007 Jun;142(6):526-31;

Yan TD, Chu F, Black D, King DW, Morris DL. Synchronous resection of colorectal primary cancer and liver metastases. World J Surg. 2007 Jul;31(7):1496-501.

Mollevi DG, Serrano T, Ginesta MM, Valls J, Torras J, Navarro M, Ramos E, Germa JR, Jaurrieta E, Moreno V, Figueras J, Capella G, Villanueva A. Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis. 2007 Jun;28(6):1241-6.

Nishio H, Hamady ZZ, Malik HZ, Fenwick S, Rajendra Prasad K, Toogood GJ, Lodge JP. Outcome following repeat liver resection for colorectal liver metastases.
Eur J Surg Oncol. 2007 Aug;33(6):729-34.

Konishi T, Watanabe T, Kishimoto J, Kotake K, Muto T, Nagawa H; Japanese Society for Cancer of the Colon and Rectum. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007 Jun;56(6):863-8.

Yan TD, Chu F, Black D, King DW, Morris DL.  Synchronous Resection of Colorectal Primary Cancer and Liver Metastases. World J Surg. 2007 May 30;


Bodingbauer M, Tamandl D, Schmid K, Plank C, Schima W, Gruenberger T. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg. 2007 May 18;

Malik HZ, Gomez D, Wong V, Al-Mukthar A, Toogood GJ, Lodge JP, Prasad KR. Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur J Surg Oncol. 2007 Mar 8;

Jovine E, Biolchini F, Talarico F, Lerro FM, Mastrangelo L, Selleri S, Landolfo G, Martuzzi F, Iusco DR, Lazzari A. Major hepatectomy in patients with synchronous colorectal liver metastases: whether or not a contraindication to simultaneous colorectal and liver resection? Colorectal Dis. 2007 Mar;9(3):245-52.

Figueras J, Torras J, Valls C, Llado L, Ramos E, Marti-Rague J, Serrano T, Fabregat J.  Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis Colon Rectum. 2007 Apr;50(4):478-88.

Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S.  Long-term characteristics of 5-year survivors after liver resection for colorectal metastases. Ann Surg Oncol. 2007 Apr;14(4):1336-46.

Ruers TJ, Joosten JJ, Wiering B, Langenhoff BS, Dekker HM, Wobbes T, Oyen WJ, Krabbe PF, Punt CJ.  Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol. 2007 Mar;14(3):1161-9

Thelen A, Jonas S, Benckert C, Schumacher G, Lopez-Hanninen E, Rudolph B, Neumann U, Neuhaus P.  Repeat liver resection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol. 2007 Apr;33(3):324-8.

Lopez Andujar R, Montalva Oron E, Moya Herraiz A, Redondo Cano C, San Juan Rodriguez F, Pareja Ibars E, De Juan Burgueno M, Orbis Castellanos F, Mir Pallardo J. Reflections on 250 interventions for colorectal carcinoma metastases to the liver.] Cir Esp. 2007 May;81(5):269-75. Spanish.

Khan AZ, Karanjia ND. The impact of staging laparoscopy prior to hepatic resection for colorectal metastases. Eur J Surg Oncol. 2007 Jan 29;

Abdalla EK, Ribero D, Pawlik TM, Zorzi D, Curley SA, Muratore A, Andres A, Mentha G, Capussotti L, Vauthey JN. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg. 2007 Jan;11(1):66-72.

Thelen A, Jonas S, Benckert C, Spinelli A, Lopez-Hanninen E, Rudolph B, Neumann U, Neuhaus P. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis. 2007 Feb 21;

Bipat S, van Leeuwen MS, Ijzermans JN, Comans EF, Planting AS, Bossuyt PM, Greve JW, Stoker J. Evidence-base guideline on management of colorectal liver metastases in the Netherlands.
Neth J Med. 2007 Jan;65(1):5-14. Review.

Figueras J, Torras J, Valls C, Llado L, Ramos E, Marti-Rague J, Serrano T, Fabregat J. Surgical Resection of Colorectal Liver Metastases in Patients with Expanded Indications: A Single-Center Experience with 501 Patients. Dis Colon Rectum. 2007 Feb 7;

Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007 Feb 15;109(4):718-26.

Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases. Ann Surg Oncol. 2007 Apr;14(4):1336-46.

Baize N, Gerard B, Bleiberg H, Caroli-Bosc F, Berthier F, Legendre H, Pector JC, Hendlisz A. Long-term survival of patients downstaged by oxaliplatin and 5-fluorouracil combination followed by rescue surgery for unresectable colorectal liver metastases. Gastroenterol Clin Biol. 2006 Dec;30(12):1349-53.

Ruers TJ, Joosten JJ, Wiering B, Langenhoff BS, Dekker HM, Wobbes T, Oyen WJ, Krabbe PF, Punt CJ. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol. 2007 Mar;14(3):1161-9.

Antoniou A, Lovegrove RE, Tilney HS, Heriot AG, John TG, Rees M, Tekkis PP, Welsh FK. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases.
Surgery. 2007 Jan;141(1):9-18.

Welter S, Jacobs J, Krbek T, Poettgen C, Stamatis G. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg. 2007 Feb;31(2):167-72.

Muratore A, Zorzi D, Bouzari H, Amisano M, Massucco P, Sperti E, Capussotti L. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol. 2007 Feb;14(2):766-70.

Capussotti L, Vigano' L, Ferrero A, Lo Tesoriere R, Ribero D, Polastri R. Timing of resection of liver metastases synchronous to colorectal tumor: proposal of prognosis-based decisional model.
Ann Surg Oncol. 2007 Mar;14(3):1143-50.

Antoniou A, Lovegrove RE, Tilney HS, Heriot AG, John TG, Rees M, Tekkis PP, Welsh FK. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases.
Surgery. 2007 Jan;141(1):9-18.

Lee WS, Yun SH, Chun HK, Lee WY, Yun HR, Kim J, Kim K, Shim YM. Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis. 2006 Nov 16;  

Kanjo T, Albertini M, Weber S. Long-term disease-free survival after adrenalectomy for isolated colorectal metastases. Asian J Surg. 2006 Oct;29(4):291-3. 

Sperti E, Faggiuolo R, Gerbino A, Magnino A, Muratore A, Ortega C, Ferraris R, Leone F, Capussotti L, Aglietta M. Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach.
Dis Colon Rectum. 2006 Oct;49(10):1596-601.  

Yedibela S, Klein P, Feuchter K, Hoffmann M, Meyer T, Papadopoulos T, Gohl J, Hohenberger W. Surgical management of pulmonary metastases from colorectal cancer in 153 patients.
Ann Surg Oncol. 2006 Nov;13(11):1538-44. 

de Geus-Oei LF, Wiering B, Krabbe PF, Ruers TJ, Punt CJ, Oyen WJ. FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma. Ann Oncol. 2006 Nov;17(11):1650-5.

Machi J, Oishi AJ, Sumida K, Sakamoto K, Furumoto NL, Oishi RH, Kylstra JW. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J. 2006 Jul-Aug;12(4):318-26.

Osborne D, Pappas E, Alexander G, Boe B, Cantor AB, Rosemurgy A, Zervos E. A complication-free course ensures a survival advantage in patients after regional therapy for metastatic colorectal cancer. Am Surg. 2006 Jun;72(6):505-10.

Iizasa T, Suzuki M, Yoshida S, Motohashi S, Yasufuku K, Iyoda A, Shibuya K, Hiroshima K, Nakatani Y, Fujisawa T.  Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg. 2006 Jul;82(1):254-60.

Oussoultzoglou E, Bachellier P, Rosso E, Scurtu R, Lucescu I, Greget M, Jaeck D. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg. 2006 Jul;244(1):71-9.

Titu LV, Breen DJ, Nicholson AA, Hartley J, Monson JR. Is routine magnetic resonance imaging justified for the early detection of resectable liver metastases from colorectal cancer? Dis Colon Rectum. 2006 Jun;49(6):810-5.

Capussotti L, Muratore A, Mulas MM, Massucco P, Aglietta M. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg. 2006 Aug;93(8):1001-6

Langenhoff BS, Krabbe PF, Peerenboom L, Wobbes T, Ruers TJ. Quality of life after surgical treatment of colorectal liver metastases. Br J Surg. 2006 Aug;93(8):1007-14.

Elias D, Benizri E, Pocard M, Ducreux M, Boige V, Lasser P.Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol. 2006 Aug;32(6):632-6.  

Avital I, DeMatteo R. Combined resection of liver and lung metastases for colorectal cancer. Thorac Surg Clin. 2006 May;16(2):145-55, vi.

Elias D, Benizri E, Pocard M, Ducreux M, Boige V, Lasser P. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer.
Eur J Surg Oncol. 2006 Apr 15;

Shaw IM, Rees M, Welsh FK, Bygrave S, John TG. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg. 2006 Apr;93(4):457-64.

Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006 May;13(5):668-76.

Homsi J, Garrett CR. Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer. Cancer Control. 2006 Jan-Feb;13(1):42-7. 

Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE 2nd, Zhang C, Mayer RJ. Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481).
J Clin Oncol. 2006 Mar 20;24(9):1395-403.
 

Yoon SS, Kim SH, Gonen M, Heffernan NM, Detwiller KY, Jarnagin WR, D'Angelica M, Blumgart LH, Tanabe KK, Dematteo RP. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol. 2006 Mar;13(3):353-62. 

Masi G, Cupini S, Marcucci L, Cerri E, Loupakis F, Allegrini G, Brunetti IM, Pfanner E, Viti M, Goletti O, Filipponi F, Falcone A. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
Ann Surg Oncol. 2006 Jan;13(1):58-65.  

Shimada H, Tanaka K, Matsuo K, Togo S. Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch Surg. 2005 Dec 1;:1-13

Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol. 2005 Nov 20;23(33):8490-9.  

Torzilli G, Montorsi M, Donadon M, Palmisano A, Del Fabbro D, Gambetti A, Olivari N, Makuuchi M. "Radical but conservative" is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg. 2005 Oct;201(4):517-28. 

Nagano Y, Nojiri K, Matsuo K, Tanaka K, Togo S, Ike H, Shimada H. The impact of advanced age on hepatic resection of colorectal liver metastases. J Am Coll Surg. 2005 Oct;201(4):511-6.  

McIntosh J, Sylvester PA, Virjee J, Callaway M, Thomas MG. Pulmonary staging in colorectal cancer - is computerised tomography the answer? Ann R Coll Surg Engl. 2005 Sep;87(5):331-3. 

Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg. 2005 Sep;92(9):1155-60. 

Jones OM, Rees M, John TG, Bygrave S, Plant G. Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection.
Br J Surg. 2005 Sep;92(9):1165-8. 

Shiono S, Ishii G, Nagai K, Yoshida J, Nishimura M, Murata Y, Tsuta K, Kim YH, Nishiwaki Y, Kodama T, Iwasaki M, Ochiai A. Predictive factors for local recurrence of resected colorectal lung metastases. Ann Thorac Surg. 2005 Sep;80(3):1040-5.

Zubeldia JM, Bednarczyk EM, Baker JG, Nabi HA. The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases.
Cancer Biother Radiopharm. 2005 Aug;20(4):450-6. 

Wang P, Chen Z, Huang WX, Liu LM. Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: a literature review of randomized control trials. World J Gastroenterol. 2005 Jul 7;11(25):3817-22.  

Allen PJ, Nissan A, Picon AI, Kemeny N, Dudrick P, Ben-Porat L, Espat J, Stojadinovic A, Cohen AM, Fong Y, Paty PB. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg. 2005 Jul;201(1):57-65.

Cartwright T, Lopez T, Vukelja SJ, Encarnacion C, Boehm KA, Asmar L. Results of a Phase II Open-Label Study of Capecitabine in Combination with Irinotecan as First-Line Treatment for Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2005 May;5(1 

Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist. 2005 Apr;10(4):250-61. 

Elias D, Baton O, Sideris L, Boige V, Malka D, Liberale G, Pocard M, Lasser P. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases.
J Surg Oncol. 2005 Apr 1;90(1):36-42. 

Child PW, Yan TD, Perera DS, Morris DL. Surveillance-detected hepatic metastases from colorectal cancer had a survival advantage in seven-year follow-up. Dis Colon Rectum. 2005 Apr;48(4):744-8.  

Ogata Y, Matono K, Hayashi A, Takamor S, Miwa K, Sasatomi T, Ishibashi N, Shida S, Shirouzu K. Repeat pulmonary resection for isolated recurrent lung metastases yields results comparable to those afte first pulmonary resection in colorectal cancer. World J Surg. 2005 Mar;29(3):363-8.  

Chafai N, Chan CL, Bokey EL, Dent OF, Sinclair G, Chapuis PH. What factors influence survival in patients with unresected synchronous liver metastases after resection of colorectal cancer? Colorectal Dis. 2005 Mar;7(2):176-81.

Ogata Y, Matono K, Hayashi A, Takamor S, Miwa K, Sasatomi T, Ishibashi N, Shida S, Shirouzu K. Repeat Pulmonary Resection for Isolated Recurrent Lung Metastases Yields Results Comparable to Those after First Pulmonary Resection in Colorectal Cancer. World J Surg. 2005 Feb 10 

Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Ishizu K, Yasuda S, Makuuchi H, Murayama C. Estimation of the time of pulmonary metastasis in colorectal cancer patients with isolated synchronous liver metastasis. Jpn J Clin Oncol. 2005 Jan;35(1):18-22. 

Koch M, Kienle P, Hinz U, Antolovic D, Schmidt J, Herfarth C, von Knebel Doeberitz M, Weitz J. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg. 2005 Feb;241(2):199-205 

Yamamoto H, Nagino M, Kamiya J, Hayakawa N, Nimura Y. Surgical treatment for colorectal liver metastases involving the paracaval portion of the caudate lobe. Surgery. 2005 Jan;137(1):26-32.

Christophi C, Nikfarjam M, Malcontenti-Wilson C, Muralidharan V. Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy.World J Surg. 2004 Oct;28(10):987-94.  

Zalcberg JR, Kemeny NE. Systemic or regional chemotherapy for liver metastases from colorectal cancer: has the wheel stopped spinning? Cancer J. 2004 Sep-Oct;10(5):271-9.  

Conzelmann M, Linnemann U, Berger MR. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use? Int J Colorectal Dis. 2004 Sep 30;  

Aschele C, Debernardis D, Lonardi S, Bandelloni R, Casazza S, Monfardini S, Gallo L. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy. J Clin Oncol. 2004 Sep 15;22(18):3758-65.

Kopp I, Bauhofer A, Koller M. Understanding quality of life in patients with colorectal cancer: comparison of data from a randomised controlled trial, a population based cohort study and the norm reference population. Inflamm Res. 2004 Aug;53 Suppl 2:S130-5. Epub 2004 Aug 10. 

Teague BD, Morrison CP, Court FG, Chin VT, Costello SP, Kirkwood ID, Maddern GJ. Role of FDG-PET in surgical management of patients with colorectal liver metastases. ANZ J Surg. 2004 Aug;74(8):646-52.  

Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004 Aug 17;141(4):264-71  

Fietkau R, Zettl H, Klocking S, Kundt G. Incidence, Therapy and Prognosis of Colorectal Cancer in Different Age GroupsA Population-Based Cohort Study of the Rostock Cancer Registry. Strahlenther Onkol. 2004 Aug;180(8):478-87. 

Lin J, Zhang SM, Cook NR, Rexrode KM, Lee IM, Buring JE. Body mass index and risk of colorectal cancer in women (United States). Cancer Causes Control. 2004 Aug;15(6):581-9.  

Vogt C, Cohnen M, Beck A, vom Dahl S, Aurich V, Modder U, Haussinger D. Detection of colorectal polyps by multislice CT colonography with ultra-low-dose technique: comparison with high-resolution videocolonoscopy.
Gastrointest Endosc. 2004 Aug;60(2):201-9. 

Van Breda SG, Van Agen E, Engels LG, Moonen EJ, Kleinjans JC, Van Delft JH. Altered vegetable intake affects pivotal carcinogenesis pathways in colon mucosa from adenoma patients and controls. Carcinogenesis. 2004 Jul 22

Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF.Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr. 2004 Jul 14  

UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ. 2004 Jul 17;329(7458):133 

Davies RJ, Collins CD, Vickery CJ, Eyre-Brook I, Welbourn R. Reduction in the proportion of patients with colorectal cancer presenting as an emergency following the introduction of fast-track flexible sigmoidoscopy: a three-year prospective observational study. Colorectal Dis. 2004 Jul;6(4):265-7. 

Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004 Jun;126(7):1674-80. 

Brown G, Davies S, Williams GT, Bourne MW, Newcombe RG, Radcliffe AG, Blethyn J, Dallimore NS, Rees BI, Phillips CJ, Maughan TS. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer. 2004 Jul 5;91(1):23-9.  

Loeve F, van Ballegooijen M, Boer R, Kuipers EJ, Habbema JD. Colorectal cancer risk in adenoma patients: a nation-wide study. Int J Cancer. 2004 Aug 10;111(1):147-51 

Rabeneck L, Paszat LF. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Am J Gastroenterol. 2004 Jun;99(6):1141-4. 

Bandipalliam P, Balmana J, Syngal S. Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors. Surgery. 2004 Jun;135(6):683-9.

Rosa F, Meimarakis G, Stahl A, Bumm R, Hahn K, Tatsch K, Dresel S. Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease. Nuklearmedizin. 2004 Aug;43(4):135-40. 

Teague BD, Morrison CP, Court FG, Chin VT, Costello SP, Kirkwood ID, Maddern GJ. Role of FDG-PET in surgical management of patients with colorectal liver metastases. ANZ J Surg. 2004 Aug;74(8):646-52. 

Vogelsang H, Haas S, Hierholzer C, Berger U, Siewert JR, Prauer H. Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg. 2004 Aug;91(8):1066-71.  

Negri F, Musolino A, Cunningham D, Pastorino U, Ladas G, Norman AR. Retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer: the development of a preoperative chemotherapy strategy. Clin Colorectal Cancer. 2004 Jul;4(2):101-6.

Yasui K, Shimizu Y, Hirai T, Kanemitsu Y, Kato T. Surgical treatment for colorectal liver metastases--results of multi-institute study for effects of radical hepatectomy Gan To Kagaku Ryoho. 2004 May;31(5):690-4.  

Julianov A, Karashmalakov A, Rachkov I, Hristov H. Treatment of colorectal cancer with synchronous bilobar liver metastases with simultaneous bowel and liver resection plus radiofrequency ablation.
Hepatogastroenterology. 2004 May-Jun;51(57):643-5.  

Dawson LA, Lawrence TS. The role of radiotherapy in the treatment of liver metastases. Cancer J. 2004 Mar-Apr;10(2):139-44.  

Elaraj DM, Alexander HR. Current role of hepatic artery infusion and isolated liver perfusion for the treatment of colorectal cancer liver metastases. Cancer J. 2004 Mar-Apr;10(2):128-38. 

Nelson RL, Freels S. A systematic review of hepatic artery chemotherapy after hepatic resection of colorectal cancer metastatic to the liver. Dis Colon Rectum. 2004 May;47(5):739-45. Epub 2004 Mar 25.  

Tanaka K, Shimada H, Miura M, Fujii Y, Yamaguchi S, Endo I, Sekido H, Togo S, Ike H. Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World J Surg. 2004 Mar;28(3):263-70.

Tanaka K, Shimada H, Miura M, Fujii Y, Yamaguchi S, Endo I, Sekido H, Togo S, Ike H. Metastatic Tumor Doubling Time: Most Important Prehepatectomy Predictor of Survival and Nonrecurrence of Hepatic Colorectal Cancer Metastasis. World J Surg. 2004 Feb

 King J, Glenn D, Clark W, Zhao J, Steinke K, Clingan P, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg. 2004 Feb;91(2):217-23.

 Reddy RH, Kumar B, Shah R, Mirsadraee S, Papagiannopoulos K, Lodge P, Thorpe JA. Staged pulmonary and hepatic metastasectomy in colorectal cancer--is it worth it? Eur J Cardiothorac Surg. 2004 Feb;25(2):151-4

 Kanemitsu Y, Kato T, Hirai T, Yasui K. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg. 2004 Jan;91(1):112-20.

 Shimada H, Tanaka K, Masui H, Nagano Y, Matsuo K, Kijima M, Ichikawa Y, Ike H, Ooki S, Togo S. Results of surgical treatment for multiple (>/=5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg. 2004 Jan 9

 Patel NA, Keenan RJ, Medich DS, Woo Y, Celebrezze J, Santucci T, Maley R, Landreneau RL, Roh MS. The presence of colorectal hepatic metastases does not preclude pulmonary metastasectomy. Am Surg. 2003 Dec;69(12):1047-53; discussion 1053.

 Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results. Radiology. 2003 Dec;229(3):821-9.

Fukunaga K, Takada Y, Otsuka M, Todoroki T, Fukao K.  Resection of localized recurrences after hepatectomy of colorectal cancer metastases. Hepatogastroenterology. 2003 Nov-Dec;50(54):1894-7.

Linnemann U, Schimanski CC, Gebhardt C, Berger MR.  Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations. Int J Colorectal Dis. 2003 Nov 21 [Epub ahead of print]

Watanabe I, Arai T, Ono M, Sugito M, Kawashima K, Ito M, Nagai K, Saito N. Prognostic factors in resection of pulmonary metastasis from colorectal cancer. Br J Surg. 2003 Nov;90(11):1436-40.

Pfannschmidt J, Muley T, Hoffmann H, Dienemann H.  Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg. 2003 Sep;126(3):732-9.

Mineo TC, Ambrogi V, Tonini G, Bollero P, Roselli M, Mineo D, Nofroni I. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg. 2003 Sep;197(3):386-91.

Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003 Sep;90(9):1131-6.

Higashiyama M, Kodama K, Higaki N, Takami K, Murata K, Kameyama M, Yokouchi H. Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis. Jpn J Thorac Cardiovasc Surg. 2003 Jul;51(7):289-96.

Metcalfe MS, Close JS, Iswariah H, Morrison C, Wemyss-Holden SA, Maddern GJ. The value of laparoscopic staging for patients with colorectal metastases. Arch Surg. 2003 Jul;138(7):770-2.

Naredi P, Oman M, Blind PJ, Lindner P, Gustavsson B, Hafstrom L. A comparison between hepatic artery ligation and portal 5-Fu infusion versus 5-Fu intra arterial infusion for colorectal liver metastases. Eur J Surg Oncol. 2003 Jun;29(5):459-66.

Ishikawa K, Hashiguchi Y, Mochizuki H, Ozeki Y, Ueno H. Extranodal cancer deposit at the primary tumor site and the number of pulmonary lesions are useful prognostic factors after surgery for colorectal lung metastases. Dis Colon Rectum. 2003 May;46(5):629-36.

Taschieri AM, Elli M, Vignati GA, Montecamozzo G, Danelli PG, Kurihara H, Poliziani D. Repeated liver resection for recurrent metastases from colorectal cancer. Hepatogastroenterology. 2003 Mar-Apr;50(50):472-4.

Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg. 2003 May;90(5):567-74.

Prall F, Gringmuth U, Nizze H, Barten M.  Microvessel densities and microvascular architecture in colorectal carcinomas and their liver metastases: significant correlation of high microvessel densities with better survival. Histopathology. 2003 May;42(5):482-91.

Tanaka S, Umekita N, Maeshiro T, Miyamoto Y, Inoue S, Matsuo S, Kitamura M.
A clinical scoring system may identify good candidates for hepatic arterial infusion chemotherapy after hepatic resection for colorectal cancer
Gan To Kagaku Ryoho. 2002 Nov;29(12):2283-5. Japanese.

Tanada M, Nakata M, Kubo Y, Saeki H, Aogi K, Ishizaki M, Kurita A, Takashima S.

Pulmonary resection for metastatic colorectal cancer
Gan To Kagaku Ryoho. 2002 Nov;29(12):2135-7. Japanese.

Tono T, Kanoh T, Nakano Y, Okada K, Murakami M, Asaoka T, Takemoto H, Imazato M, Matsui S, Iwazawa T, Yano H, Kinuta M, Okamura J, Monden T.

Reasonable approach for prophylactic hepatic arterial infusion chemotherapy after potentially curative surgery for colorectal liver metastases
Gan To Kagaku Ryoho. 2002 Nov;29(12):2129-31. Japanese.

Kato T, Kikkawa N, Yamamoto K, Yasumoto S, Tsujie M, Iijima S, Naoi Y, Hayashi T, Tanigawa T, Yamamoto H, Kurokawa E.

Complications related to hepatic arteria infusion chemotherapy for liver metastasis]
Gan To Kagaku Ryoho. 2002 Nov;29(12):2125-8. Japanese.

Soma I, Kanai T, Fukuchi N, Izawa H, Yoshida T, Ebisui C, Sakita I, Fujimoto T.

Evaluation of hepatic arterial infusion chemotherapy with levofolinate (l-LV) and 5-fluorouracil (5-FU) for multiple liver metastases from colorectal cancer
Gan To Kagaku Ryoho. 2002 Nov;29(12):2121-3. Japanese.

Yoshimura K, Hazama S, Iizuka N, Takano N, Matsuoka K, Tangoku A, Oka M.

Hepatic arterial infusion of IL-2 and chemotherapy for unresectable liver metastasis from colorectal cancer
Gan To Kagaku Ryoho. 2002 Nov;29(12):2117-20. Japanese.

Kiyonaga H, Miyashita K, Yamaguchi K, Todoroki H, Aizawa K, Okumura N.

Evaluation of intra-arterial infusion chemotherapy for liver metastasis from colorectal cancer
Gan To Kagaku Ryoho. 2002 Nov;29(12):2112-5. Japanese.

Kurihara A, Nakazaki H, Watanabe M, Hasebe Y, Takita W, Seo A, Takata M, Kobayashi K, Teramoto T, Hirano K.
Hepatectomy and intraarterial infusion chemotherapy for liver metastasis from colorectal cancer
Gan To Kagaku Ryoho. 2002 Nov;29(12):2104-7. Japanese.

Tsuji Y, Hamada H, Yasuda D, Okamura M, Watanabe K, Takahashi T, Takada J, Katsuki Y.

Resection made possible following hepatic arterial infusion in 2 cases of hepatic metastases from colorectal cancer
Gan To Kagaku Ryoho. 2002 Nov;29(12):2100-3. Japanese.

Kane JM 3rd, Kahlenberg MS, Rodriguez-Bigas MA, Gibbs JF, Petrelli NJ. Intraoperative hepatic lymphatic mapping in patients with liver metastases from colorectal carcinoma. Am Surg. 2002 Sep;68(9):745-50.

Alexander HR Jr, Libutti SK, Bartlett DL, Pingpank JF, Kranda K, Helsabeck C, Beresnev T.     Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
Cancer. 2002 Aug 15;95(4):730-6.

Yamaguchi J, Komuta K, Matsuzaki S, Okudaira S, Fujioka H, Kanematsu T. Mode of infiltrative growth of colorectal liver metastases is a useful predictor of recurrence after hepatic resection.
World J Surg. 2002 Sep;26(9):1122-5.

Ike H, Shimada H, Togo S, Yamaguchi S, Ichikawa Y, Tanaka K.
Sequential resection of lung metastasis following partial hepatectomy for colorectal cancer.
Br J Surg. 2002 Sep;89(9):1164-8.

Labow DM, Buell JE, Yoshida A, Rosen S, Posner MC.
Isolated pulmonary recurrence after resection of colorectal hepatic metastases--is resection indicated?
Cancer J. 2002 Jul-Aug;8(4):342-7.

Liu LX, Zhang WH, Jiang HC, Zhu AL, Wu LF, Qi SY, Piao DX.
Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.
World J Gastroenterol. 2002 Aug;8(4):663-7.

de Santibanes E, Lassalle FB, McCormack L, Pekolj J, Quintana GO, Vaccaro C, Benati M.
Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and longterm outcomes.
J Am Coll Surg. 2002 Aug;195(2):196-202.

Barry BD, Kell MR, Redmond HP.
Tumor lysis syndrome following endoscopic radiofrequency interstitial thermal ablation of colorectal liver metastases.
Surg Endosc. 2002 Jul;16(7):1109

Mala T, Edwin B, Gladhaug I, Fosse E, Soreide O, Bergan A, Mathisen O.
A comparative study of the short-term outcome following open and laparoscopic liver resection of colorectal metastases. Surg Endosc. 2002 Jul;16(7):1059-63.

Yamada H, Katoh H, Kondo S, Okushiba S, Morikawa T.
Surgical treatment of pulmonary recurrence after hepatectomy for colorectal liver metastases. Hepatogastroenterology. 2002 Jul-Aug;49(46):976-9.

Sasaki A, Aramaki M, Kawano K, Yasuda K, Inomata M, Kitano S.
Prognostic significance of intrahepatic lymphatic invasion in patients with hepatic resection due to metastases from colorectal carcinoma.
Cancer. 2002 Jul 1;95(1):105-11.

Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, Yamamoto J, Yamaguchi T, Muto T, Makuuchi M. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg. 2002 Jul;137(7):833-40.

Kemeny M. Hepatic artery infusion of chemotherapy as a treatment for hepatic metastases from colorectal cancer. Cancer J. 2002 May-Jun;8 Suppl 1:S82-8.

Yamaguchi J, Komuta K, Matsuzaki S, Okudaira S, Fujioka H, Kanematsu T. Mode of Infiltrative Growth of Colorectal Liver Metastases Is a Useful Predictor of Recurrence after Hepatic Resection. World J Surg. 2002 May 29 [epub ahead of print]

Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S, Encke A, Blumgart L, Fong Y. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002 Jun;235(6):863-71. Review.

Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002 Jun;235(6):759-66.

Ike H, Shimada H, Ohki S, Togo S, Yamaguchi S, Ichikawa Y. Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up.
Dis Colon Rectum. 2002 Apr;45(4):468-73; discussion 473-5.

Clavien PA, Selzner N, Morse M, Selzner M, Paulson E. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy.
Surgery. 2002 Apr;131(4):433-42.

Rizk NP, Downey RJ. Resection of pulmonary metastases from colorectal cancer. Semin Thorac Cardiovasc Surg. 2002 Jan;14(1):29-34.

Malik U, Mohiuddin M.
External-beam radiotherapy in the management of liver metastases. Semin Oncol. 2002 Apr;29(2):196-201. Review.

Sotsky TK, Ravikumar TS.
Cryotherapy in the treatment of liver metastases from colorectal cancer. Semin Oncol. 2002 Apr;29(2):183-91. Review.

Parikh AA, Curley SA, Fornage BD, Ellis LM.
Radiofrequency ablation of hepatic metastases. Semin Oncol. 2002 Apr;29(2):168-82. Review.

Sato T.
Locoregional immuno(bio)therapy for liver metastases. Semin Oncol. 2002 Apr;29(2):160-7. Review.

Herba MJ, Thirlwell MP.
Radioembolization for hepatic metastases. Semin Oncol. 2002 Apr;29(2):152-9.

Sullivan KL.
Hepatic artery chemoembolization. Semin Oncol. 2002 Apr;29(2):145-51. Review.

Weinreich DM, Alexander HR.
Transarterial perfusion of liver metastases. Semin Oncol. 2002 Apr;29(2):136-44. Review.

Dizon DS, Kemeny NE.
Intrahepatic arterial infusion of chemotherapy: clinical results. Semin Oncol. 2002 Apr;29(2):126-35. Review.

Ensminger WD.
Intrahepatic arterial infusion of chemotherapy: pharmacologic principles. Semin Oncol. 2002 Apr;29(2):119-25. Review.

Sasson AR, Sigurdson ER.
Surgical treatment of liver metastases. Semin Oncol. 2002 Apr;29(2):107-18. Review.

Evans HS, Moller H, Robinson D, Lewis CM, Bell CM, Hodgson SV.
The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut. 2002 May;50(5):647-52.

Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, Sigurdson ER, O'Dwyer PJ, Benson AB 3rd.
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study. J Clin Oncol. 2002 Mar 15;20(6):1499-505.

Su WT, Brachman M, O'Connell TX
Use of oncoscint scan to assess resectability of hepatic metastases from colorectal cancer. Am Surg. 2001 Dec;67(12):1200-3.

Link KH, Sunelaitis E, Kornmann M, Schatz M, Gansauge F, Leder G, Formentini A, Staib L, Pillasch J, Beger HG. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival. Cancer. 2001 Dec 1;92(11):2746-53.

Tsuji Y, Hamada H, Satou A, Kudou T, Hasegawa K, Okada M, Takada J, Katsuki Y, Ohira S.
[Consideration of surgical treatment for recurrence after the resection of hepatic metastases from colorectal cancer] Gan To Kagaku Ryoho. 2001 Oct;28(11):1621-3. Japanese.

Yukawa N, Akaike M, Sugimasa Y, Takemiya S, Motohashi H.
[Therapeutic strategy for hepatic metastasis of primary colon cancer] Gan To Kagaku Ryoho. 2001 Oct;28(11):1565-8. Japanese.

Noura S, Sekimoto M, Yamamoto H, Ikeda M, Ikenaga M, Miyake Y, Yokoyama S, Nagano H, Sakon M, Monden M.
[Significance of liver resection for multiple hepatic metastases from colorectal cancer] Gan To Kagaku Ryoho. 2001 Oct;28(11):1550-3. Japanese.

Morita T, Shibata T, Tsukahara Y, Kitada M, Fukushima Y, Hata S, Fujita J, Ikeda K, Hayashida H, Okuyama M, Nakata S, Ishida T, Shimano T. [Indication for surgical and microwave coagulation therapy for multiple (> or = 5) bilobar liver metastases from colorectal cancer] Gan To Kagaku Ryoho. 2001 Oct;28(11):1501-4. Japanese.

Gruenberger T, Jourdan JL, Zhao J, King J, Morris DL.
Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg. 2001 Oct;136(10):1154-7.

Saha S, Bardelli A, Buckhaults P, Velculescu VE, Rago C, St Croix B, Romans KE, Choti MA, Lengauer C, Kinzler KW, Vogelstein B.
A phosphatase associated with metastasis of colorectal cancer. Science. 2001 Nov 9;294(5545):1343-6.

Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, Cova L, Halpern EF, Gazelle GS.
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001 Oct;221(1):159-66.

Crowe PJ, Yang JL, Berney CR, Erskine C, Ham JM, Fisher R, Russell PJ.
Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer. World J Surg. 2001 Aug;25(8):996-1001.

Yamada H, Kondo S, Okushiba S, Morikawa T, Katoh H.
Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg. 2001 Sep;25(9):1129-33.

Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, Cova L, Halpern EF, Gazelle GS.
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001 Oct;221(1):159-66.

Nagakura S, Shirai Y, Hatakeyama K.
Computed tomographic features of colorectal carcinoma liver metastases predict posthepatectomy patient survival. Dis Colon Rectum. 2001 Aug;44(8):1148-54.

Weber JC, Nakano H, Bachellier P, Oussoultzoglou E, Inoue K, Shimura H, Wolf P, Chenard-Neu MP, Jaeck D.
Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am J Surg. 2001 Jul;182(1):81-8.

Biasco G, Gallerani E.
Treatment of liver metastases from colorectal cancer: what is the best approach today? Dig Liver Dis. 2001 Jun-Jul;33(5):438-44.

Malafosse R, Penna C, Sa Cunha A, Nordlinger B.
Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol. 2001 Jul;12(7):887-94.

Lyass S, Zamir G, Matot I, Goitein D, Eid A, Jurim O.
Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol. 2001 Sep;78(1):17-21.

Cyjon A, Neuman-Levin M, Rakowsky E, Greif F, Belinky A, Atar E, Hardoff R, Brenner B, Sulkes A.
Liver metastases from colorectal cancer: regional intra-arterial treatment following failure of systemic chemotherapy. Br J Cancer. 2001 Aug 17;85(4):504-8.

Zanon C, Grosso M, Clara R, Alabiso O, Chiappino I, Miraglia S, Martinotti R, Bortolini M, Rizzo M, Gazzera C.
Combined regional and systemic chemotherapy by a mini-invasive approach for the treatment of colorectal liver metastases. Am J Clin Oncol. 2001 Aug;24(4):354-9.

Moroz P, Jones SK, Gray BN.
Status of hyperthermia in the treatment of advanced liver cancer. J Surg Oncol. 2001 Aug;77(4):259-69. Review.

Yamada H, Katoh H, Kondo S, Okushiba S, Morikawa T.
Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer. Hepatogastroenterology. 2001 May-Jun;48(39):828-30.

Piedbois P, Zelek L, Cherqui D.
Chemotherapy of nonoperable colorectal liver metastases. Hepatogastroenterology. 2001 May-Jun;48(39):711-4.

Figueras J, Valls C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E.
Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg. 2001 Jul;88(7):980-5.

Nippon Geka Gakkai Zasshi 2000 Aug;101(8):568-73 The role of prophylactic hepatic arterial infusion chemotherapy after potentially curative resection of hepatic metastases from colorectal cancer [Article in Japanese] Tono T, Monden T

Ann Thorac Surg 2000 Aug;70(2):380-3 Surgery for pulmonary metastases from colorectal carcinoma. Inoue M, Kotake Y, Nakagawa K, Fujiwara K, Fukuhara K, Yasumitsu T

Cancer 2000 Jul 15;89(2):285-7 Distribution of colorectal liver metastases in patients referred for hepaticresection. Wigmore SJ, Madhavan K, Redhead DN, Currie EJ, Garden OJ

Cancer 2000 Jul 15;89(2):276-84 Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Shibata T, Niinobu T, Ogata N, Takami M

Cancer 2000 Jul 15;89(2):267-75 Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma.Clinicopathologic study of 152 first resection cases. Okano K, Yamamoto J, Kosuge T, Yamamoto S, Sakamoto M, Nakanishi Y, Hirohashi S

Am Surg 2000 Jul;66(7):611-5 Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Cervone A, Sardi A, Conaway GL

Surgery 2000 May;127(5):528-35 Aggressive surgical approach to recurrent tumors after hepatectomy formetastatic spread of colorectal cancer to the liver. Imamura H, Kawasaki S, Miyagawa S, Ikegami T, Kitamura H, Shimada R

Dis Colon Rectum 2000 Jan;43(1):44-9 Prospective, blinded comparison of laparoscopic ultrasonography vs.contrast-enhanced computerized tomography for liver assessment in patients undergoing colorectal carcinoma surgery. Milsom JW, Jerby BL, Kessler H, Hale JC, Herts BR, O'Malley CM

Arch Surg 2000 Apr;135(4):473-9; discussion 479-80 Interval hepatic resection of colorectal metastases improves patient selection. Lambert LA, Colacchio TA, Barth RJ Jr

Ann Surg 2000 May;231(5):743-51 Survival after resection of multiple bilobar hepatic metastases from colorectalcarcinoma. Bolton JS, Fuhrman GM

Eur J Surg Oncol 2000 Apr;26(3):199-202 Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone. Finlay IG, Seifert JK, Stewart GJ, Morris DL

Ann Surg 2000 Apr;231(4):487-99 Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, Yamamoto J, Imamura H

Ann Surg 2000 Apr;231(4):480-6 Resection of nonresectable liver metastases from colorectal cancer afterpercutaneous portal vein embolization. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoine A, Bismuth H

Ann Surg 2000 Apr;231(4):471-9 Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. Lodge JP, Ammori BJ, Prasad KR, Bellamy MC

Cancer 2000 Apr 1;88(7):1549-56 Limited but definite efficacy of prophylactic hepatic arterial infusionchemotherapy after curative resection of colorectal liver metastases: A randomized study. Tono T, Hasuike Y, Ohzato H, Takatsuka Y, Kikkawa N

Swiss Surg 2000;6(1):6-10 Colorectal liver metastases: does the number of metastases determine ofresection is oncologically indicated? [Article in German]Knoefel WT, Brunken C, Neumann E, Gundlach M, Rogiers X, Izbicki JR

Chirurgie 1999 Dec;124(6):640-8 Adjuvant intra-arterial chemotherapy after curative resection of liver metastasis from colorectal cancer. Results of a pilot study in 30 patients [Article in French] Gambiez L, Denimal F, Karoui M, Dewailly V, Pruvot FR, Quandalle P

J Gastrointest Surg 2000 Mar-Apr;4(2):178-84 Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y

J Clin Oncol 2000 Jan;18(2):243-54 Randomized, multicenter trial of fluorouracil plus leucovorin administeredeither via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. Lorenz M, Muller HH

N Engl J Med 1999 Dec 30;341(27):2039-48 Hepatic arterial infusion of chemotherapy after resection of hepatic metastasesfrom colorectal cancer. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, TurnbullAD, Sullivan D, Stockman J, Blumgart LH, Fong Y

Rev Mal Respir 1999 Nov;16(5):809-15 Surgical treatment of pulmonary metastases of colorectal cancers. 8-yearsurvival and main prognostic factors [Article in French] Baron O, Hamy A, Roussel JC, Galetta D, al Habash O, Duveau D, Despins P, de Lajartre AY, Michaud JL

J Thorac Cardiovasc Surg 1999 Dec;118(6):1090-6 Surgical treatment for both pulmonary and hepatic metastases from colorectalcancer. Kobayashi K, Kawamura M, Ishihara T

Am J Surg 1999 Oct;178(4):275-81 Repeat liver resection for recurrent colorectal liver metastases. Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Moriya Y, Sugihara K

Gan To Kagaku Ryoho 1999 Oct;26(12):1756-8 Is portal infusion chemotherapy uneffective for hepatic recurrence after resection for colorectal cancer? [Article in Japanese] Yamamura T, Akaishi O, Tsukikawa S, Yamaguchi S, Yabe K

Gan To Kagaku Ryoho 1999 Oct;26(12):1698-701 Efficacy of adjuvant hepatic arterial infusion chemotherapy following resection of colorectal liver metastases. [Article in Japanese] Ota M, Masui H, Tanaka K, Ichikawa Y, Yamaguchi S, Togo S, Ike H, Oki S, Shimada H

Minerva Chir 1999 May;54(5):325-30 Intra-arterial chemotherapy in the treatment of liver metastases of colorectal cancer. [Article in Italian] Lupo F, Lisuzzo A, Cajozzo M, Vitale D, La Mendola G, Di Tora P, Bazan P

Ann Oncol 1999 Jun;10(6):663-9 Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, Brienza S, Alafaci E, Bertheault-Cvitkovic F, Jasmin C, Reynes M, Bismuth H, Misset JL, Levi F

Langenbecks Arch Surg 1999 Jun;384(3):243-9 Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Rudroff C, Altendorf-Hoffmann A, Stangl R, Scheele J

Chirurgie 1999 Jun;124(3):258-63 Surgical strategy in the treatment of synchronous hepatic metastases of colorectal cancers. Analysis of a series of 59 operated on patients. [Article in French] Jaeck D, Bachellier P, Weber JC, Boudjema K, Mustun A, Paris F, Schaal JC, Wolf P

Eur J Surg Oncol 1999 Aug;25(4):381-8 Downstaging by regional chemotherapy of non-resectable isolated colorectal livermetastases. Link KH, Pillasch J, Formentini A, Sunelaitis E, Leder G, Safi F, Kornmann M, Beger HG

Ann Surg 1999 Jul;230(1):31-7 Selection of patients for resection of colorectal metastases to the liver usingdiagnostic laparoscopy and laparoscopic ultrasonography. Rahusen FD, Cuesta MA, Borgstein PJ, Bleichrodt RP, Barkhof F, Doesburg T,Meijer S

Br J Radiol 1999 Mar;72(855):246-9 Does resection of small liver metastases from colorectal cancer improve survivalof patients? Irie T, Itai Y, Hatsuse K, Mochizuki H

Hepatogastroenterology 1999 Mar-Apr;46(26):1065-70 Survival after repeat hepatic resection for recurrent colorectal metastases. Chiappa A, Zbar AP, Biella F, Staudacher C

Dis Colon Rectum 1999 May;42(5):632-9 Hepatic resection for colorectal metastases: analysis of prognostic factors.Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H, Kusashio K, Furuya S, Nakajima N

Arch Bronconeumol 1999 Apr;35(4):183-6 Survival after resection of lung metastasis from colorectal cancer. [Article in Spanish] Hoyuela C, Rami Porta R, Mateu Navarro M, Cugat E, Bretcha P, Marco C

Am J Surg 1999 Apr;177(4):294-8 Aggressive surgical resection for hepatic metastases involving the inferior vena cava. Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Okuno A, Nukui Y, Yoshitomi H, Kusashio K, Furuya S, Nakajima N

Br J Surg 1999 Mar;86(3):332-7 Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H

Int Surg 1998 Oct-Dec;83(4):340-2 The time interval between primary colorectal carcinoma resection to occurrence of liver metastases is the most important factor for hepatic resection. Analysis of total course following primary resection of colorectal cancer. Sato T, Konishi K, Yabushita K, Nojima N, Kimura H, Maeda K, Tsuji M, Miwa A

Jpn J Clin Oncol 1999 Feb;29(2):78-86 Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agentsafter curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials. Sakamoto J, Hamada C, Kodaira S, Nakazato H, Ohashi Y

Gastroenterol Clin Biol 1998 Dec;22(12):1048-55 What are the real indications for hepatectomies in metastases of colorectal origin? [Article in French] Elias D, Ducreux M, Rougier P, Sabourin JC, Cavalcanti A, Bonvalot S, Debaene B, Antoun S, Pignon JP, Lasser P

Chirurg 1998 Dec;69(12):1334-9 Is resection of colorectal liver metastases still justified in very elderlypatients? [Article in German]Brunken C, Rogiers X, Malago M, Hillert C, Zornig C, Busch C, Izbicki JR, Broelsch CE

J Thorac Cardiovasc Surg 1999 Jan;117(1):66-75; discussion 75-6 Is resection of pulmonary and hepatic metastases warranted in patients withcolorectal cancer? Robinson BJ, Rice TW, Strong SA, Rybicki LA, Blackstone EH

Ann Surg Oncol 1998 Dec;5(8):706-12 Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases. Kokudo N, Seki M, Ohta H, Azekura K, Ueno M, Sato T, Moroguchi A, Matsubara T, Takahashi T, Nakajima T, Aiba K

Ann Surg 1998 Dec;228(6):756-62 Randomized trial of surgery versus surgery followed by adjuvant hepatic arterialinfusion with 5-fluorouracil and folinic acid for liver metastases of colorectalcancer. German Cooperative on Liver Metastases. Lorenz M, Muller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K, Hauss J, Stieger R, Jauch KW, Bechstein WO, Encke A

Surg Today 1998;28(7):707-13 Micrometastatic colorectal cancer lesions in the liver. Nanko M, Shimada H, Yamaoka H, Tanaka K, Masui H, Matsuo K, Ike H, Oki S, Hara M

Ann Thorac Surg 1998 Jul;66(1):214-8; discussion 218-9 Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Regnard JF, Grunenwald D, Spaggiari L, Girard P, Elias D, Ducreux M, Baldeyrou P, Levasseur P

Hepatogastroenterology 1998 May-Jun;45(21):805-11 Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy. Asahara T, Kikkawa M, Okajima M, Ojima Y, Toyota K, Nakahara H, Katayama K, Itamoto T, Marubayashi S, One E, Yahata H, Dohi K, Azuma K, Ito K